000 01342 a2200349 4500
005 20250515073238.0
264 0 _c20080408
008 200804s 0 0 eng d
022 _a1569-1993
024 7 _a10.1016/j.jcf.2007.05.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilms, E B
245 0 0 _aPharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients.
_h[electronic resource]
260 _bJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
_cJan 2008
300 _a79-84 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aAzithromycin
_xadministration & dosage
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutrophils
_xdrug effects
650 0 4 _aSputum
_xchemistry
700 1 _aTouw, D J
700 1 _aHeijerman, H G M
773 0 _tJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
_gvol. 7
_gno. 1
_gp. 79-84
856 4 0 _uhttps://doi.org/10.1016/j.jcf.2007.05.005
_zAvailable from publisher's website
999 _c17136364
_d17136364